OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
22
Results
Show all
Save search
Copy query
Show results for
Unknown
(22)
Publication Date
Release Date
2024
(4)
2025
(2)
2023
(2)
2022
(2)
2021
(2)
2010
(2)
2026
(1)
2020
(1)
2017
(1)
2015
(1)
2013
(1)
2012
(1)
2007
(1)
2006
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data.
Not available
S-EPMC2938201
|
biostudies-literature
Cite
National Institute of Neurological Disorders and Stroke Common Data Element Project - approach and methods.
Not available
S-EPMC3513359
|
biostudies-literature
Cite
Randomized clinical trial evaluating intravitreal ranibizumab or saline for vitreous hemorrhage from proliferative diabetic retinopathy.
Not available
S-EPMC4217122
|
biostudies-literature
Cite
Clinical trial recommendations for potential Alport syndrome therapies.
Not available
S-EPMC7614298
|
biostudies-literature
Cite
Effects of empagliflozin on quality of life and healthcare use and costs in chronic kidney disease: a health economic analysis of the EMPA-KIDNEY trial.
Not available
S-EPMC12274867
|
biostudies-literature
Cite
Vessel and balloon sizing in the IN.PACT AV access trial: post-hoc analysis of procedural characteristics and outcomes.
Not available
S-EPMC12906498
|
biostudies-literature
Cite
Genetic association study of exfoliation syndrome identifies a protective rare variant at LOXL1 and five new susceptibility loci.
Not available
S-EPMC6685441
|
biostudies-literature
Cite
Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project.
Not available
S-EPMC2212820
|
biostudies-literature
Cite
Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial.
Not available
S-EPMC7615591
|
biostudies-literature
Cite
Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial.
Not available
S-EPMC7618536
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets